Takeda

Takeda Mulls Bid for Shire

TiGenix and Takeda Get EU Nod for Crohn’s Therapy

The German Capital Region

The German capital region is one of the leading life sciences and healthcare industries centers in the world. A total of around 30,000 employees work in more than 500 companies in the pharma, the biotech and the medtech industry.

AstraZeneca and Takeda in Parkinson’s Pact

Arix, LDC and Leeds University in Metabolic Pact

Ariad Shareholders Sue Over Takeda Deal

Takeda to Take Ariad for $5.2 Billion

Takeda to Expand Cancer Drug Plant in Dublin

Valeant-Takeda Talks Said off

Valeant Selling Salix to Takeda?

Crescendo Biologics and Takeda in Cancer Drug Pact

Sanofi Pasteur Wins US Zika Vaccine Aid

Takeda Gets US Funding for Zika Vaccine

Takeda Appoints Kehoe as New Chief Financial Officer

DCAT Week ’16

AstraZeneca Seals Three Drug Deals

Teva and Takeda in Japanese Generics JV

Drugmakers Launch UK Dementia Fund

Takeda Said Offering $2.2 Billion to Settle Actos Lawsuits

Fired Sanofi CEO to Receive $4.4 Million Severance Pay

U.S. Court Fines Takeda, Lilly $9 billion Over Diabetes Drug Safety

iBIO and iBIO Institute Boards Elect Andy Hull and Linda Friedman as 2014 Chairs

Onyx Provides Drug Trial Data to Amgen, Other Potential Bidders

China Blocks GSK Finance Head From Leaving Country

Teva, Sun Pharma to Pay $2.15 Billion to Settle Pfizer Patent Suit

Affymax, Takeda Recall Anemia Drug Omontys After Deaths

Lundbeck's Alcohol Dependency Drug Gets EU Green Light

Drug Industry Treading Water on R&D Productivity

U.S. Supreme Court to Review Lawsuits over Flaws in Generic Drugs

Thriving Generics

Watson Sues FDA on Generic Diabetes Drug Ruling

Amgen Q2 Profit Beats Estimates

Takeda Chases Emerging Market Sales with Brazil Buy

Japan's Asahi Kasei to buy U.S. Zoll for $2.2 Billion

E&Y Sees $1-5 Billion As Sweet Spot For Biotech M&A